Literature DB >> 16176873

An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations.

Jordanna Joaquina Coelho1, Angela Arnold, Jeremy Nayler, Marc Tischkowitz, James MacKay.   

Abstract

There are few published studies regarding the use of telemedicine in counselling families with a history of cancer. In this study, cancer genetic counselling was evaluated when conducted via telemedicine and compared to face-to-face consultations. Participants were placed into a telemedicine group or a face-to-face group depending on their geographical location. Telemedicine consultations took place using real-time videoconferencing technology ISDN6 digital telephone lines. Sixteen participants were evaluated in the telemedicine compared to 21 in the face-to-face group and all participants were asked to complete both a precounselling and postcounselling questionnaire, which assessed their understanding of cancer genetics, anxiety levels, satisfaction levels, and allowed for personal comments. In both the telemedicine and face-to-face groups, a significant reduction in cancer related anxiety levels and high satisfaction levels were reported. There was a trend towards increased cancer genetic knowledge post genetic counselling in both groups. The results show that telemedicine is a useful alternative by which to provide cancer genetic services when geographical distance is an issue.

Entities:  

Mesh:

Year:  2005        PMID: 16176873     DOI: 10.1016/j.ejca.2005.06.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  34 in total

1.  Bridging the distance: a prospective tele-oncology study in Northern Norway.

Authors:  Tom Donnem; Bente Ervik; Kathrine Magnussen; Sigve Andersen; Doris Pastow; Sissel Andreassen; Tone Nørstad; Nina Helbekkmo; Roy M Bremnes; Tone Nordoy
Journal:  Support Care Cancer       Date:  2011-11-11       Impact factor: 3.603

2.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

3.  Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Authors:  Adam H Buchanan; Santanu K Datta; Celette Sugg Skinner; Gail P Hollowell; Henry F Beresford; Thomas Freeland; Benjamin Rogers; John Boling; P Kelly Marcom; Martha B Adams
Journal:  J Genet Couns       Date:  2015-04-03       Impact factor: 2.537

4.  Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.

Authors:  Neal J Meropol; Mary B Daly; Hetal S Vig; Frank J Manion; Sharon L Manne; Carla Mazar; Camara Murphy; Nicholas Solarino; Vadim Zubarev
Journal:  J Telemed Telecare       Date:  2010-11-19       Impact factor: 6.184

5.  Delivery of cancer genetics services: The Royal Marsden telephone clinic model.

Authors:  S Shanley; K Myhill; R Doherty; A Ardern-Jones; S Hall; C Vince; S Thomas; P Aspinall; R Eeles
Journal:  Fam Cancer       Date:  2007-05-17       Impact factor: 2.375

6.  Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.

Authors:  Ellen Otten; Erwin Birnie; Adelita V Ranchor; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

7.  Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services.

Authors:  Nan M Solomons; Amanda E Lamb; Frances L Lucas; Eileen F McDonald; Susan Miesfeldt
Journal:  Telemed J E Health       Date:  2017-07-21       Impact factor: 3.536

8.  Telemedicine uptake among Genetics Professionals in Europe: room for expansion.

Authors:  Ellen Otten; Erwin Birnie; Anneke M Lucassen; Adelita V Ranchor; Irene M Van Langen
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

9.  Impact of delivery models on understanding genomic risk for type 2 diabetes.

Authors:  S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg
Journal:  Public Health Genomics       Date:  2014-02-27       Impact factor: 2.000

10.  Public trust in genomic risk assessment for type 2 diabetes mellitus.

Authors:  Rachel Mills; William Barry; Susanne B Haga
Journal:  J Genet Couns       Date:  2013-12-03       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.